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Background: Increased antibiotic resistance of common bacteria is attributed in part
to the widespread use of various antibiotic agents. Prophylactic and therapeutic
antibiotic treatments are routinely used in cardiac surgical units, and it is no surprise
that methicillin-resistant Staphylococcus aureus infection is becoming a major
cause of surgical infections in cardiac patients.
Methods: We reviewed our experience with patients who underwent cardiac surgery
and experienced infection caused by methicillin-resistant Staphylococcus aureus.
Between 1992 and 2000 at the Montreal Heart Institute, 39 patients had methicillin-
resistant Staphylococcus aureus surgical infections, and 13,199 patients underwent
cardiac surgery. The yearly incidence of methicillin-resistant Staphylococcus
aureus infection, the relative risk of acute mediastinitis and of superficial wound
infections or other types of methicillin-resistant Staphylococcus aureus infection
episodes, and the effect of preventive measures were analyzed.
Results: The annual incidence of methicillin-resistant Staphylococcus aureus acute
mediastinitis decreased from 0.37% (5/1321) of cardiac patients in 1992 and 0.44%
(6/1355) in 1993 to 0% between 1994 and 1997, 0.13% (2/1528) in 1999, and 0%
(0/1700) in 2000. The total incidence of methicillin-resistant Staphylococcus aureus
infection, including mediastinitis, superficial and deep sternal and leg wound infec-
tion, and all systemic infection episodes ranged from 0.68% of patients in 1992 and
0.96% of patients in 1993 to 0.46% of patients in 1999 and 0.53% of patients in
2000. The relative risk of severe mediastinal methicillin-resistant Staphylococcus
aureus infection to all other methicillin-resistant Staphylococcus aureus infection
episodes decreased from 1.65 in 1992 to 0.41 in 1999 and 0 in 2000. Beginning in
1993, all patients given a diagnosis methicillin-resistant Staphylococcus aureus
infection and all nasal carriers of methicillin-resistant Staphylococcus aureus were
strictly isolated on the surgical unit, and vancomycin was used as the prophylactic
antibiotic agent for cardiac surgery in these patients. Moreover, since 1998, all
patients admitted in the hospital were screened, and nasal carriers were isolated and
treated with topical antibiotic ointment.
Conclusion: Mediastinal and other infections caused by methicillin-resistant
Staphylococcus aureus have a significant morbidity in cardiac surgical patients.
After an outbreak of methicillin-resistant Staphylococcus aureus mediastinal infec-
tions, several preventive measures to control methicillin-resistant Staphylococcus
aureus contamination of surgical patients were implemented (nasal screening, pre-
ventive isolation, application of mupirocin, prophylaxis with vancomycin and alco-
hol gels) and were effective in decreasing the incidence of methicillin-resistant
Staphylococcus aureus infection and mediastinitis after cardiac surgery.
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Surgical infections, either wound or systemicinfections, are frequent causes of morbidityand mortality after cardiac surgery. Althoughthe incidence of sternal wound infectionremains lower than 2% to 3%, several patientshave bloodstream and systemic infections dur-
ing and immediately after a hospital stay for cardiac
surgery.1,2 Gordon and colleagues2 have suggested that
Staphylococcus aureus was the most common organism
causing bloodstream infection after cardiac surgery, and
Mossad and colleagues3 identified that Staphylococcus epi-
dermidis was emerging as a significant agent causing sternal
wound infection. Of interest, 92% of isolated coagulase-neg-
ative staphylococci were methicillin resistant in the latter
study. Whereas short-term antibiotic prophylaxis of less than
48 hours was proved effective in decreasing surgical-site
infections after cardiac surgery,4 prolonged use beyond 48
hours after the operation was not only shown ineffective in
preventing surgical infection, but it was also correlated with
an increased risk of acquired antibiotic resistance.5
In 1992, we encountered an outbreak of methicillin-
resistant Staphylococcus aureus (MRSA) infections in our
cardiac surgical unit. Preventive and therapeutic measures
were adopted. The objective of the present study is to
review the effect of anti-MRSA preventive measures on the
incidence of MRSA infection after cardiac surgery.
Methods
Hospital Setting
The Montreal Heart Institute is a tertiary cardiac care facility of
155 beds with 24 surgical intensive care units and 29 regular sur-
gical cardiac care beds. Seventy-five percent of our surgical
patients are referred from surrounding hospitals for cardiac
catheterization and cardiac surgery.
Patients who underwent cardiac surgery between 1992 and
2000 were administered preoperative and postoperative antibiotic
prophylaxis with either cefazolin or vancomycin for penicillin-
allergic patients. The antibiotics were administered during the first
24 hours after the operation.
Definition of the Type of Infection
Sternal wound infections were classified as superficial infections
characterized by purulent drainage from the wound with cuta-
neous and subcutaneous involvement, deep wound infections were
classified as involving deep soft fascial and muscular tissue, and
acute mediastinitis was defined by a purulent drainage involving
the sternal bone and surrounding mediastinal tissue.6 All suspected
surgical wounds (sternal and leg wounds), urine, bronchial secre-
tion, and blood in febrile patients were cultured.
Active surveillance of all infections occurring in surgical
patients was performed by a clinical nurse specializing in infec-
tious epidemiology and complications. We retrospectively
reviewed all patients with MRSA-positive cultures and all patients
with mediastinal infections after cardiac surgery during the study
period.
Preventive Measures
From 1993 to 2000, all patients given a diagnosis of MRSA infec-
tion and all nasal carriers of MRSA identified by means of preop-
erative screening of surgical patients were strictly isolated from all
other patients in a private room on the surgical unit before and
after surgical intervention. Vancomycin was used as the prophy-
lactic antibiotic agent for cardiac surgery in these patients. Nasal
carriers were treated with topical mupirocin antibiotic ointment.
Since 1998, all patients admitted to our hospital have been
screened, and nasal carriers are isolated and treated with topical
mupirocin ointment. Alcohol gel is also used in association with
hand washing re-enforcement. Urgent patients were also screened
and isolated if the result showed that a patient is an MRSA carrier.
The results were usually available in less than 24 hours.
Case-control Study
To analyze and compare clinical, bacteriologic, and treatment
results of MRSA acute mediastinitis, we retrospectively collected
clinical and bacteriologic data of all patients with a diagnosis of
non-MRSA acute mediastinitis during the same time period. Fifty-
one patients showed clinical evidence of acute mediastinitis and
formed the control group of our case-control analysis.
Statistical Analysis
Data are expressed as means and SDs. Differences between means
were analyzed with the Student t test, and the Fisher exact test was
used for categoric variables. The annual incidence of MRSA infec-
tion, the relative risk of acute mediastinitis, and the relative risk of
superficial wound or other types of MRSA infection episodes are
presented with 95% confidence limits. The actuarial method was
used to analyze survival in our groups of patients.
Results
Patient Population
Between 1992 and 2000, of 13,199 treated patients, 39
surgical patients had an MRSA infection episode. Thirteen
patients had acute mediastinitis, 13 patients had a superficial
sternal wound infection, and 6 patients had a leg wound infec-
tion after saphenous-vein harvesting. Five patients showed
evidence of MRSA pneumonia, and an MRSA bloodstream
infection in 2 other patients after cardiac surgery was docu-
mented. Fifty-one patients showed evidence of mediastinal
infection with non-MRSA organisms during the study period.
MRSA mediastinitis occurred in 3 patients after double
internal thoracic artery grafting, in 7 patients after single
internal thoracic artery grafting, in 2 patients after heart
transplantation, and in 1 patient after aortic valve replace-
ment. Non-MRSA mediastinitis occurred after double inter-
nal thoracic artery grafting in 10 patients, after single
internal thoracic artery grafting in 24 patients, after aortic
valve replacement in 11 patients, after coronary artery
bypass with saphenous vein grafts in 4 patients, and after
pulmonary valve replacement in 2 patients.
Non-MRSA mediastinitis was caused by Staphylococcus
aureus sensitive to methicillin in 28 (55%) of 51 patients,
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penicillin-sensitive Staphylococcus epidermidis in 8 (16%)
patients, methicillin-resistant Staphylococcus epidermidis
in 4 (6%) patients, Enterobacter cloacae in 3 (6%) patients,
Enterococcus faecalis in 2 (4%) patients, and a combination
of agents in 6 patients.
Clinical Results
There was 1 (8%) death among 13 patients with MRSA
mediastinitis, and 8 (16%) of 51 patients died after non-
MRSA acute mediastinitis (P =.7). The causes of death
were respiratory and renal failure in the patient with medi-
astinal MRSA infection and septicemia in 5 patients, medi-
astinal hemorrhage in 2 patients, and malignant arrhythmia
in 1 patient with non-MRSA mediastinal infection.
All patients with MRSA mediastinitis underwent exten-
sive operative mediastinal debridement, with pectoralis mus-
cle flaps in 5 (38%) of 13 and omentoplasty in 2 (15%) of 13
and both reconstructive procedures, pectoralis muscle flaps,
and omentoplasty in 1 patient. Nine (18%) of 51 patients with
non-MRSA mediastinitis underwent operative debridement
with pectoralis muscle flaps and 10 (20%) of 51 patients with
omentoplasty (P = .2). The others underwent mediastinal
debridement, drainage, and sternal reclosure.
Infection Rates
The first occurrence of MRSA infection in our surgical unit
was observed in 1992. The annual incidence of MRSA acute
mediastinitis varied from 0.38% (5/1321; 95% CI, 0.12-
0.88) of cardiac patients in 1992 and 0.44% (6/1355; 95%
CI, 0.16-0.96) in 1993 to 0.13% (2/1528; 95% CI, 0.02-
0.47) in 1999 and 0% in 2000. The total incidence of MRSA
infection, including mediastinitis, superficial and deep ster-
nal and leg wound infection, and all systemic infection
episodes ranged from 0.68% of patients in 1992 and 0.96%
of patients in 1993 to 0.46% of patients in 1999 and 0.53%
in 2000 (Figure 1). The relative risk of severe mediastinal
MRSA infection to all other MRSA infection episodes
decreased from 1.65 in 1992 to 0.41 in 1999 (Figure 2).
Although the rate of non-MRSA mediastinal infection
did not vary significantly during the study period, the rate
of MRSA mediastinitis decreased significantly from 11
infections during the first 2 years of the study (11/2676
[0.41%] patients) compared with only 2 mediastinal infec-
tions during the following 6 years (2/11,878 [0.02%]
patients, P = .01, Figure 3).
Discussion
The present study shows that MRSA was first isolated in
our cardiac surgical unit in 1992 from a patient with acute
mediastinitis and was followed by horizontal transmission
Figure 1. Total incidence of MRSA infections, including medias-
tinitis, superficial and deep sternal and leg wound infection, and
all systemic infection episodes decreased from 1992-1993 to 2000.
Figure 2. Relative risk (RR) of severe mediastinal MRSA infection
to all other MRSA infection episodes decreased from 1992-1993 to
2000.
Figure 3. Incidence of MRSA and non-MRSA mediastinal infec-
tions decreased from 1992-1993 to 2000.
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to 20 other patients who had various MRSA infections from
surgical wound infections to nosocomial bloodstream infec-
tions. Horizontal transmission by contiguity is suggested
because all MRSA infections occurred with the same bio-
type in a cluster of patients who underwent surgical inter-
vention during a period of 18 months. Thereafter, 4
preventive measures were initially introduced: nasal screen-
ing of all surgical patients, preventive isolation of all carri-
ers, mupirocin ointment applied to the nares of carriers, and
vancomycin antibiotic prophylaxis for cardiac surgery of
infected patients.7-10 The preventive measures eradicated
MRSA infections from 1994 to 1996, and a low rate of
MRSA infection was observed. Then a new rise in preva-
lence caused by a significant increase in patient referrals
from chronically MRSA-contaminated surrounding hospi-
tals was noticed. Nasal screening was at that time extended
to all hospitalized patients in an attempt to prevent vertical
entry from outside hospital sources and dissemination of
MRSA. At the same time, alcohol-based gel for hand wash-
ing was introduced to reduce horizontal transmission
through staff intermediates because all previous attempts at
hand washing reenforcement were not followed by a sus-
tained behavior for more than several weeks.
Thereafter, the incidence of MRSA mediastinitis after
cardiac surgery decreased significantly after the implemen-
tation of this second set of preventive measures; the inci-
dence of MRSA superficial wound infections and of other
MRSA infections remains low. A similar decrease in MRSA
infection rates in general hospital settings was reported in
Denmark after aggressive preventive measures.11
Hospital mortality was low but not significantly different
in patients with MRSA compared with those with non-
MRSA mediastinitis. MRSA microorganisms are difficult
to eradicate from mediastinal tissue, and most MRSA-
infected patients needed complex surgical procedures,
including pectoralis muscle flaps and omentoplasty.
Several authors have suggested that routine antibiotic
prophylaxis for cardiac operations has resulted in a reduc-
tion in the incidence of sternal wound infection but resulted
also in the emergence of resistant organisms.3-5 Mossad and
colleagues3 showed not only that Staphylococcus epider-
midis was responsible for 23% of sternal wound infections
in their study but that 92% were caused by methicillin-resis-
tant organisms. In the present study methicillin-sensitive
Staphylococcus aureus was isolated in 44% of patients, and
MRSA was isolated in 20% of patients with mediastinal
infections. Thus Staphylococcus aureus was the microor-
ganism involved in 64% of mediastinal infection and
remains the most important pathogen after cardiac surgery.
The epidemiology of MRSA appears linked to the
overuse of antibiotics and, in our experience, is related to
referral and transfer of patients already contaminated with
the microorganisms from hospitals in which MRSA remains
endemic. Although we found no epidemiologic links of any
case of MRSA infection, either by surgeon-specific rates,
surgical team, or nursing staff, we found a specific associa-
tion with a donated heart from a subsequently proven MRSA
blood culture–positive organ donor, resulting in recipient
mediastinal infection after transplantation and postoperative
mediastinal MRSA infection in several patients who had
been in contact with MRSA carriers in a medical unit of our
hospital before surgical intervention. Similar mechanisms of
dissemination were also reported by Doebbeling.12
Our first set of preventive measures, namely patient
screening, preventive isolation, mupirocin ointment in the
nares, and vancomycin prophylaxis implemented during the
early phase of the study, was effective in eradicating MRSA
infections from 1994 to 1996. Because MRSA infections
reappeared, albeit at a lower rate, from 1997 to 2000, a new
approach in preventive measures, taking more into account
“human factors” was applied not only in surgical units but
also in all medical units of our hospital to prevent dissemi-
nation. Mupirocin in topical application has been used to
eradicate nasal colonization with Staphylococcus aureus and
is also effective against methicillin-resistant Staphylococcus
epidermidis.13-15 In Canada screening programs for MRSA
have been the recommended guidelines in the Province of
Ontario since 1995, with a 90% institutional compliance.
Although the incidence of reported MRSA strains is on the
rise, it is observed to be mainly through nonnosocomial col-
onization, resulting in low and stable infection rates.16
Jakob and colleagues17 have not only shown that obesity,
diabetes mellitus, and nasal carriage of Staphylococcus
aureus were independent predictors of sternal wound infec-
tion after cardiac surgery but that the endogenous pathway
was responsible for the severe wound infections. In their
study 28% of patients showed colonization of the nose
before the operation, and 16% of these patients had sternal
wound infections compared with only 7% of those with nor-
mal flora in the nose before surgical intervention.
Moreover, 4 of 5 patients with mediastinitis had DNA fin-
gerprints revealing the genotype of Staphylococcus aureus
isolates from the patient’s sternum and nose to be identical.
Several authors have also stressed the significance of nasal
contamination with Staphylococcus pathogens before car-
diac surgery.18-21
The presence of nasal MRSA colonization of patients
before cardiac surgery is especially dramatic because this
can lead to direct environmental contamination and dissem-
ination to other patients. Boyce and colleagues22 showed
that 27% of inanimate surfaces sampled in rooms of patients
with MRSA were contaminated. Environmental contamina-
tion occurred in the rooms of 73% of infected patients and
67% of colonized patients. Sixty-five percent of nurses con-
taminated their nursing uniforms or gowns with MRSA when
they cared for these patients.22 Thus preventive isolation
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appears to be an appropriate measure to prevent dissemina-
tion of the resistant microorganism to other patients.
Series of MRSA outbreaks have been reported among
surgical patients in intensive care units, in pediatric intensive
care units, among chronically instrumented patients, and
among patients with previous exposure to antibiotic treat-
ment.23,24 Although series of MRSA surgical wound infec-
tions have not been described in cardiac surgical patients,
isolated cases are being reported more often in the litera-
ture.25 Moreover, the routine antibiotic prophylaxis used in
cardiac surgery, except for vancomycin, may not protect
against MRSA pathogens and can result in surgical wound
infection. In our experience MRSA microorganisms mini-
mal inhibitory concentrations showed resistance to a major-
ity of antibiotics, except vancomycin. Given the low
prevalence of methicillin and vancomycin resistance among
Staphylococcus aureus in our population, we chose to
restrict vancomycin prophylaxis to contaminated patients or
patients allergic to β-lactam and to restrict the therapeutic
use to infected patients.26 Dual or multidrug combinations
are also encouraged (eg, vancomycin and a quinolone, van-
comycin and rifampin) in hope of preventing resistance.27,28
In conclusion, preventive measures, namely nasal
screening, preventive isolation, mupirocin ointment, and
vancomycin prophylaxis limited to MRSA carriers under-
going cardiac surgery, appear efficacious in controlling
MRSA outbreaks and significantly decrease the risk of
MRSA mediastinal infection after cardiac surgery. Cardiac
patients will remain at risk of severe surgical and systemic
infection with highly resistant microorganisms unless all
health care providers implement strict measures to prevent
the dissemination of multiresistant microorganisms among
patients and between hospitals.
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